Publications - 'R'

Publications 951 - 975 de 1476
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Response of Sphagnum Peatland Testate Amoebae to a 1-Year Transplantation Experiment Along an Artificial Hydrological Gradient
K. Marcisz; B. Fournier; D. Gilbert; M. Lamentowicz; E.A.D. Mitchell
2014
10.1007/s00248-014-0367-8
Response of the authors
A. Bron; P. Koehrer; C. Creuzot-Garcher
2014
10.1007/s10792-012-9540-6
Response to Bell et al., `The effect of increasing body mass index on laparoscopic surgery for colon and rectal cancer'
S. Bell; S. Warrier
2018
10.1111/codi.14375
Response to Chaen and Trapellieni re: ``Shortening Work-Rest Durations Reduces Physiological and Perceptual Load During Uphill Walking in Simulated Cold High-Altitude Conditions,'' by Fornasiero et al.
A. Fornasiero; A. Savoldelli; F. Stella; A. Callovini; L. Bortolan; A. Zignoli; D.A. Low; L. Mourot; F. Schena; B. Pellegrini
2021
10.1089/ham.2020.0217
Response to Editor to the comment by Delarue (2016) to our paper entitled `Persistent high temperature and low precipitation reduce peat carbon accumulation'
L. Bragazza; A. Buttler; B.J.M. Robroek; R. Albrecht; C. Zaccone; V.E.J. Jassey; C. Signarbieux
2017
10.1111/gcb.13559
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
C.G. Kaderbhai; C. Richard; J.David Fumet; A. Aarnink; S. Ortiz-Cuaran; M. Perol; P. Foucher; B. Coudert; L. Favier; A. Lagrange; E. Limagne; R. Boidot; S. Ladoire; M. Poudenx; M. Ilie; P. Hofman; P. Saintigny; F. Ghiringhelli
2017
10.1080/2162402X.2017.1339856
Response to first-line chemotherapy regimen to predict efficacy of nivolumab in lung cancer.
C.Guillaume Kaderbhai; C. Richard; J.David Fumet; A. Aarnink; S. Ortiz-Cuaran; M. Perol; P. Faucher; B.P. Coudert; L. Favier; A. Lagrange; E. Limagne; P. Hofman; P. Saintigny; F. Ghiringhelli
2017
10.1200/JCO.2017.35.15_suppl.3026
Response to Letter Regarding Article, ``Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction''
D. Stub; K. Smith; S. Bernard; Z. Nehme; M. Stephenson; J.E. Bray; P. Cameron; B. Barger; A.H. Ellims; A.J. Taylor; I.T. Meredith; D.M. Kaye
2016
10.1161/CIRCULATIONAHA.115.019038
Response to Letter Regarding Article, ``Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension''
F. Mahfoud; C. Ukena; R.E. Schmieder; B. Cremers; L.C. Rump; O. Vonend; J. Weil; M. Schmidt; U.C. Hoppe; T. Zeller; A. Bauer; C. Ott; E. Blessing; P.A. Sobotka; H. Krum; M. Schlaich; M. Esler; M. Boehm
2014
10.1161/CIRCULATIONAHA.114.008029
Response to Letter Regarding Article, ``Endovascular Versus External Targeted Temperature Management for Patients With Out-of-Hospital Cardiac Arrest: A Randomized, Controlled Study''
N. Deye; A. Cariou; P. Girardie; N. Pichon; B. Megarbane; P. Midez; J.M. Tonnelier; T. Boulain; H. Outin; A. Delahaye; A. Cravoisy; A. Mercat; P. Blanc; C. Santre; H. Quintard; F. Brivet; J. Charpentier; D. Garrigue; B. Francois; J.P. Quenot; F. Vincent; P.Y. Gueugniaud; J.P. Mira; P. Carli; E. Vicaut; F.J. Baud; I.C.E.R.E.A.Study Grp
2016
10.1161/CIRCULATIONAHA.115.019996
Response to neoadjuvant chemotherapy in HER2 non-overexpressing breast cancer subtypes
S.M. Ilie; I. Desmoulins; A. Hennequin; K. Coureche-Guillaume; L. Arnould; B. Nathalie; A. Bertaut; S. Ladoire
2019
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and Fc gamma RIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
A.L. Gagez; E. Tuaillon; R. Cezar; C. Dartigeas; B. Mahe; R. Letestu; H. Maisonneuve; V. Gouilleux-Gruart; K. Bollore; E. Ferrant; T. Aurran; P. Feugier; S. Lepretre; G. Cartron
2016
10.1038/bcj.2015.115
Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience
J. Blanc; L. Kodjikian; A. Bron; C. Creuzot-Garcher
2018
10.1007/s00417-018-4095-5
Response to supplementation with lutein and zeaxanthin in subjects with familial history of AMD: the LIMPIA Study
M.N. Delyfer; M.B. Rougier; C.P. Garcher; H. Savel; G. Chene; S. Etheve; W. Schalch; C. Delcourt; J.F. Korobelnik
2014
Response to supplementation with lutein and zeaxanthin in subjects with familial history of AMD: the LIMPIA Study
M.N. Delyfer; M.B. Rougier; C.P. Garcher; H. Savel; G. Chene; S. Etheve; W. Schalch; C. Delcourt; J.F. Korobelnik
2014
Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
Y.M. Pers; M. Godfrin-Valnet; J. Lambert; C. Fortunet; E. Constant; T. Mura; B. Pallot-Prades; C. Jorgensen; J.F. Maillefert; H. Marotte; D. Wendling; P. Gaudin
2015
10.3899/jrheum.140673
RESPONSE TO TOCILIZUMAB IN RHEUMATOID ARTHRITIS IS NOT INFLUENCED BY THE BODY MASS INDEX OF THE PATIENT
Y.M. Pers; M. Godfrin-Valnet; J. Lambert; C. Fortunet; E. Constant; T. Mura; B. Pallot-Prades; C. Jorgensen; J.F. Maillefert; H. Marotte; D. Wendling; P. Gaudin
2014
10.1136/annrheumdis-2014-eular.1508
Response to `Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'-authors' reply
E. Toussirot; G. Dumoulin
2014
10.1186/ar4537
Response to ``Commenton `Piriformis muscle syndrome: Diagnostic criteria and treatment of a monocentric series of 250 patients''' by F. Michel et al.
F. Michel; P. Decavel; E. Toussirot; L. Tatu; E. Aleton; S. Nollet; P. Garbuio; B. Parratte
2016
10.1016/j.rehab.2016.03.008
Response to ``Criteria for spiritual support in critical care'' Reply
H. Winiszewski; G. Piton; G. Capellier
2018
10.1016/j.jcrc.2018.09.027
Response to: Comment on ``Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy''
G. Monseau; O. Landon-Cardinal; A.M. Bouvier; V. Jooste; A. Aouba; B. Bienvenu; O. Benveniste; Y. Allenbach; F.Myositis Network
2020
10.1016/j.jaad.2020.07.110
Response to: `Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?' by Moiseev and Novikov
M. Samson; L. Guillevin
2014
10.1136/annrheumdis-2013-204831
Response-locked component of error monitoring in psychopathy: A systematic review and meta-analysis of error-related negativity/positivity
W. Vallet; C. Neige; S. Mouchet-Mages; J. Brunelin; S. Grondin
2021
10.1016/j.neubiorev.2021.01.004
Response: A commentary on: ``Neural overlap in processing music and speech''
B. Tillmann; E. Bigand
2015
10.3389/fnhum.2015.00491
Responses of above- and below-ground fungal symbionts to cessation of mowing in subalpine grassland
M.N. Binet; D. van Tuinen; F. Souard; L. Sage; S. Perigon; C. Gallet; N. Legay; S. Lavorel; B. Mouhamadou
2017
10.1016/j.funeco.2016.10.001

Pages